Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine

Edward C Keystone, Millie M Wang, Mark Layton, Sally Hollis, Iain B McInnes

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalAnnals of the rheumatic diseases
Publication statusPublished - 2011

Cite this